chrisvoncsefalvay/vaers-outcomes huggingface dataset:
8/31: Headache right away, then dizziness and rapid heart rate starting at 6pm right after the shot. Constant clearing of throat, red, swollen, warm arm at injection site and unable to move arm over head.  9/1 Continued headache through the night into the morning, same symptoms as above with the addition to light sensitivity, muscle aches and joint pain. Unable to make fist with right hand due to joint pain and swelling. Intermittent profuse sweating. Increased SOB while walking up hill.   9/3: Same symptoms as above to include tingling and slight numbness on left side of face in the morning after waking up. By 2pm increased numbness and tingling of whole face with sharp stabbing pains in head. Brain feels foggy.
Information has been received from a registered nurse concerning a 4 year old male who was vaccinated on 6/23/00 with a dose of varicella virus vaccine live (lot # was unavailable). On 1/1/04, the patient was hospitalized for several days for lots of lesions. The child was noted to have breakthrough chicken pox. Unspecified medical attention was sought. There was no product quality complaint. The reporter indicated that 19 other patients were vaccinated with a dose of varicella virus vaccine live and developed chicken pox breakthrough/shingles (WAES0404USA00205, 0404USA00419, 0404USA00420, 0404USA00421, 0404USA00422, 0404USA00423, 0404USA00424, 0404USA00425, 0404USA00426, 0404USA00427, 0404USA00428, 0404USA00429, 0404USA00430, 0404USA00431, 0404USA00432, 0404USA00433, 0404USA00434, 0404USA00435, and 0404USA00436). No further information is expected.
Dizziness; Headache; Nausea; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), HEADACHE (Headache), NAUSEA (Nausea) and VOMITING (Vomiting) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History was provided by the reporter.   On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 24-Feb-2021, the patient experienced DIZZINESS (Dizziness), HEADACHE (Headache), NAUSEA (Nausea) and VOMITING (Vomiting).   At the time of the report, DIZZINESS (Dizziness), HEADACHE (Headache), NAUSEA (Nausea) and VOMITING (Vomiting) had not resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Received call from child's pediatrician who stated patient was in her office on 05/01/03 with fever, rash on torso and had MMR on 04/22/03.  Patient also had otitis media and swollen tonsils with poor weight gain.
I don't know if this is related to the H1N1 vaccination, however I have had a LOT of prolonged asthma symptoms for weeks which is abnormal for me, perhaps beginning around the time of my vaccine.
1 week after the injection I noticed a red sometimes itchy slightly raised area about 1 inch in diameter.  It gradually got larger and on 1/11/2021 the size increased to 2.5 inches in diameter . On 1/14 or 1/15/2021 it spread to the size of 4.5 inches in diameter. The next few days the are began to fade.
My arms felt sore soon after the injection I felt a little tired around 9:00 a.m on the 23rd. and then extreme fatigue chills and body aches around 7:00 p.m.
This is a spontaneous report from a contactable pharmacist. This pharmacist reported 2 cases. This is 2 of 2 cases. A 55-year-old male patient received PREVNAR 13 (Lot # L62074, Expiry Date Nov2016, NDC# 00005197102) subcutaneous at 0.5 ml, single on 26Jun2015. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced cellulitis of the left arm on 30Jun2015 and fever of 100.4 on 27Jun2015. The outcome of the events was unknown. Patient was admitted to the hospital for 2 nights with cellulitis of the left arm. He was given antibiotics during his hospital stay. The patient was also hospitalized for fever from 30Jun2015 to an unknown date. Hospital discharge date was unknown. The relatedness of drug to event Cellulitis was unknown.
I received the vaccine at 10:45AM on 04/08/2021. At around 4:30PM, I began experiencing waves of nausea and lethargy. By 7:00PM, I had a fever of about 101 F. By 8:30PM, my fever was exactly 103.46F. It was then that I took medication to bring the fever down.  The fever broke overnight while sleeping. Since then, I continue to experience episodes of annoying brain fog. With hope, this will pass soon.
Presented with SOB; previous covid exposure; Covid + in ED; CXR and CT without PNA; Tx: Remdesivir, Decadron, Vit C, Zinc, antibiotics, lovenox, Vit D3, singulair;  had encephalopathy due to covid; improving at d/c; on room air at time of d/c
pretty sick from the last vaccine; worse after second dose, felt bad; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (pretty sick from the last vaccine) and FEELING ABNORMAL (worse after second dose, felt bad) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 095A21A and 089A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (pretty sick from the last vaccine) and FEELING ABNORMAL (worse after second dose, felt bad). At the time of the report, ILLNESS (pretty sick from the last vaccine) and FEELING ABNORMAL (worse after second dose, felt bad) outcome was unknown.            No concomitant medications were provided. No treatment medications were provided.   This case was linked to MOD-2021-370435, MOD-2021-370409, MOD-2021-370422 (Patient Link).
Whole Body tightened up with Tremors. Compressed feeling in chest lasted 10 minutes. Woke up hours later with fever, headache and back pain.
Light headedness, balance issues; nausea intermittent over 5 days  Primary care doctor not consulted  Second dose on 2/27/2021-no side effects
Patient had slight throat tightness, dry cough and flushed.  Benadryl 25 mg given by mouth. Observed for 30 min and all symptoms resolved.
Information has been received from a registered nurse concerning an otherwise healthy 4 year old female who on 30-AUG-2007 was vaccinated with an IM dose of ProQuad (Enders-Edmonston, Jeryl Lynn, Wistar RA 27/3, Oka/Merck upgrade process) instead of a subcutaneous dose in the left arm.  Concomitant vaccinations that day included an IM dose of DTaP in the left arm and an IM dose of IPV (unspecified) in the left arm.  On 31-AUG-2007 the patient may have developed possible cellulitis characterized by the arm that swollen, red and draining.  The child had no fever.  Medical attention was sought via doctor visit the next day following vaccination.  The patient was treated with KEFLEX 1.5 teaspoonfuls twice a day in addition to a needed follow-up in a couple of days.  It was unknown if there has been any improvement since treatment with KEFLEX.  There was no product quality complaint.  Additional information has been requested.
Dizziness, chronic flu like symptoms, progressive fatigue, joint & muscle pain-severe pain throughout body- headaches & throbbing, brain fog, body throbbing. Disorientation, memory loss-unable to formulate words or think coherently, "brain fog"- heart palpitations, nausea, inability to perform job, insomnia-inability to function-many days would remain in bed, feeling like I had been hit or run over by a truck- constant feeling that I was going to cry & frequent weeping, social isolation, severe anxiety & depression.  8/27/09 PCP medical records received 8/7/03 to 10/03/05. Assessment: musculoskeletal pain. Patient presents with post traumatic stress, hypoglycemia, insomnia, menopause and diffuse musculoskeletal pain. Low energy, feels like crying. achy. Acupuncture treatment.  Melanoma dx'd on back - surgery.
On 02/01/2002 pt presented to office with rash all over body. Mom noticed rash 2 days prior. Was advised by MD to use Caladryl lotion and increase fluids. Parents were educated regarding diagnosis and no steroid use.
Some redness and little swelling on left deltoid, painful.  Apply warm compress then cold pak RTC if not improve.
Patient experienced itchiness, redness, swelling, and soreness at injection site and within 3-4 inches around site. Max response was at about 2 days after injection, has been using anti-itch topical with success for 3 days, and site is improving.
Patient describes sporadic tingling in left arm and numbness in left hand since time of injection at around 12:00pm today.
Within first 30 minute: eyes itchy and watery, lips tingling. On 6/14/2021 (3rd day after shot): both sides of body-arms and hands got numb, weak and tingly. Hands were difficult to move. Both sides of jaw got numb and tight. Lips were extremely tingly.
Mother states child broke out with bright, red, itchy hives over most of her body. No temp. voice hoarse. Treated with Benadryl- No Dr. visit required. Symptoms lasted approx 12-18 hrs.
Lightheadedness that won't go away; If someone tells me something, it would take some moments for me to answer; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Lightheadedness that won't go away) and FEELING ABNORMAL (If someone tells me something, it would take some moments for me to answer) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced DIZZINESS (Lightheadedness that won't go away) and FEELING ABNORMAL (If someone tells me something, it would take some moments for me to answer). At the time of the report, DIZZINESS (Lightheadedness that won't go away) and FEELING ABNORMAL (If someone tells me something, it would take some moments for me to answer) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment details were reported.
No adverse reaction, vaccine was given before appropriate age. Patient was 4 years 7 months.
01/17/22 presents to ED for "RUQ pain". PMHx of "DM2, CAD and MIs (2016 s/p PCI with 3 stents and 2020), Roux-en-Y bypass in 2017, umbilical hernia repair"
Patient called nurse triage the morning of 11/20/22, reporting he received both the influenza and pneumonia shot, in the right arm, Friday morning 11/18/22. He had a new rash, was feverish during the night. Right arm is sore, tender. He came to the urgent care clinic connected to the pharmacy the same morning, was diagnosed with cellulitis, and given sulfamethoxazole-trimethoprim to treat the infection.
cough; runny nose; fatigue; headache; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough), RHINORRHOEA (runny nose), FATIGUE (fatigue) and HEADACHE (headache) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced COUGH (cough), RHINORRHOEA (runny nose), FATIGUE (fatigue) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, COUGH (cough), RHINORRHOEA (runny nose), FATIGUE (fatigue) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Feb-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included anti-hypertensives.
A third dose of ROTARIX given at 6 month appt. Recommended is a 2 dose series. Patient asymptomatic currently.
Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Tiredness) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) for Plaque psoriasis.    No Medical History information was reported.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) (Subcutaneous) at an unspecified dose. In 2021, the patient experienced FATIGUE (Tiredness). At the time of the report, FATIGUE (Tiredness) was resolving.            No concomitant medication information was provided. The patient felt tired possibly due to the Covid Vaccine shot. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. No treatment medication was provided. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
expired doses administered; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired doses administered) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012H21B) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired doses administered). On 11-Jan-2022, EXPIRED PRODUCT ADMINISTERED (expired doses administered) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   On December 6, 2021, Lot 012H21B vials were placed  in refrigerator. No concomitant medication were provided. No treatment information were given.   This case was linked to MOD-2022-448109 (Patient Link).
Rash over whole body, greatest on bilateral legs.  Rash  is raised and itchy, had some that appeared blistery yesterday. Medical provider gave  Hydroxyzine 25 mg, every 6 hours
This spontaneous report as received from a pharmacist refers to a 61 year old patient. On 05-SEP-2014 the patient was vaccinated with an expired dose of PNEUMOVAX 23, lot # J009827, expiration date 10-AUG-2014, dose and route not reported. No adverse effects reported. Additional information is not expected.
Information has been received from a physician concerning a female who on 05-MAR-2007 was vaccinated with a dose of Gardasil (yeast) (lot # 654747/1208F). In March 2007, "a few days after receiving the shot" the patient experienced headache, dizziness, stiff neck and shoulders. Unspecified medical attention was sought. The patient's headache, dizziness, stiff neck and shoulders persisted. No product quality complaint was involved. Additional information has been requested.
Violent uncontrollable shaking; Loss of motor control; Sensations of electricity shooting; Shooting through my body; High fever; Headache; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the arm left on 30Apr2021 at 12:30 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the arm left on 09Apr2021 at (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01May2021 at 02:45, the patient experienced violent uncontrollable shaking that occurred in waves and patterns for approximately 1 hour, loss of motor control and sensations of electricity shooting through his body, high fever and headache for the next two days. The clinical outcomes of violent uncontrollable shaking, loss of motor control and sensations of electricity shooting through his body, high fever and headache were recovering.   No follow-up attempts are needed. No further information is expected.
I contracted COVID-19 with symptoms of fever of 99, fatigue, mild cough, earache, and tinnitus was severe. I was prescribed an antibiotic by my PCP who refused to prescribe PAXLOVID. I went to an urgent care where I was prescribed PAXLOVID on 10/19/22. I was ill for 3 days before my symptoms began to resolve. I had lingering symptoms of earache and tinnitus which just resolved last week.
Joint pain; Joint stiffness; humira was not effective as before; This is a spontaneous report based on the information received by Pfizer. A contactable consumer of a 65-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number & Expiry date not reported) via unspecified route of administration on 05Mar2021 (at age of 65-year-old) as dose 2, single for COVID-19 Immunisation. Patient medical history include alcohol use occasionally, four to five glass of wines per week from 1973, tobacco user from 2002 to 2007, premature atrial con-traction, penicillin (penicillin allergy manifested by tissue swelling). Patient concomitant medications include adalimumab (Humira, solution for injection in pre-filled pen, 40 mg, 1 in 2 week) used for ankylosing spondylitis rheumatoid arthritis from sep2018 to an unspecified date. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number & Expiry date not reported) via Intra-muscular route of administration on 06Feb2021 as dose 1, single for COVID-19 Immunisation and experienced pulse rapid, dizziness, flu like symptoms, weakness, feeling abnormal, Ankylosing spondylitis. On 12Apr2021 (one month, 7 days) after vaccination of second dose patient experienced Joint pain, Joint stiffness. On 12Apr2021, the patient experienced Humira was not effective as before, joint pain and joint stiffness. primary reporter did not have the lot number information, because the packaging was discarded. The patient was treated with prednisone. The reporter & as causality for the event of Humira was not effective as before, joint pain, joint stiffness and feeling like been run over by truck with Humira was a reasonable possibility. The outcome of events was not recovered.    Follow-up attempts are needed. Further information is expected.  Follow-up (29Jul2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient reported that he had a 102 degree fever the night of 8/14/20 after receiving the Fluad Quadravalent vaccine on 8/13/20. The fever worsened to 105 degrees the night of 8/15/20. He treated at home with Tylenol and his temperature returned to normal on 8/16/20.
Vax at 09:15, Left arm pain that progressed within 3 hours to entire arm, including wrist pain, unable to lift arm. Fever began 6 hours post vax, along with pain (level 6/10 progressing to  8/10 at peak fever)  in lower back, and neck, and some sternal pain/anxious feeling. Fever peaked at 12 hours post vax at 102.9. Fever down to 101.5 the next morning upon rising, and down to 100.5 by 08:30 that morning (about 24 hours post vax). At 24 hours post vax, still somewhat weak, with head/neck/back pain, but improving, down to 5/10 on pain scale. Did NOT treat with medications, treated with lots of fluids, rest.
Pt reported frontal headaches, daily since day of vax. No prior history of recurrent headaches. Partial relief with Tylenol.
Pt's arm became swollen, arm indurated area 11 cm X 7 cm. When doctor examined it 2 days later, he first believed it to be a cellulitis secondary to a bug bite, but now believe it to be reaction to hepatitis A vaccine.
77 patients received Moderna bivalent booster doses that had undergone a temperature excursion.; Product storage error; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (77 patients received Moderna bivalent booster doses that had undergone a temperature excursion.), PRODUCT STORAGE ERROR (Product storage error) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7140C) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (77 patients received Moderna bivalent booster doses that had undergone a temperature excursion.), PRODUCT STORAGE ERROR (Product storage error) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (77 patients received Moderna bivalent booster doses that had undergone a temperature excursion.), PRODUCT STORAGE ERROR (Product storage error) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (77 patients received Moderna bivalent booster doses that had undergone a temperature excursion.) and PRODUCT STORAGE ERROR (Product storage error).    This case contains information for the 11 out of 77 adult patients described by the reporter. No concomitant information was reported. It was reported that, Approximately 77 patients received Moderna bivalent booster doses that had undergone a temperature excursion. The doses were administered before it was known if the vaccine was ok to use after the excursion. No treatment information was reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-696122 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-696122:Master case
8:45 felt tingling went into neck when vaccine adm. in (L) Deltoid. 10:30 - Felt lump in collar bone area - slightly below- moves when moving arm slightly painful- went to ER 10/19 & PMD 10/21 on- Ibuprofen then to see PMD- Possible antibiotics.